17 February 2016 - A Florida company involved in an unusual race for approval of a drug that treats a rare neuromuscular condition had a setback on Wednesday, after federal regulators said they needed more information before deciding whether to approve it.

For more details, go to: http://www.nytimes.com/2016/02/18/health/fda-deals-setback-to-catalyst-in-race-for-drug-approval.html?_r=0